Bicycle Therapeutics PLC (BCYC)
20.54
+0.28
(+1.38%)
USD |
NASDAQ |
Nov 22, 16:00
20.57
+0.03
(+0.15%)
After-Hours: 20:00
Bicycle Therapeutics Free Cash Flow: -203.53M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -203.53M |
| June 30, 2024 | -164.79M |
| March 31, 2024 | -85.93M |
| December 31, 2023 | -63.56M |
| September 30, 2023 | -47.98M |
| June 30, 2023 | -55.30M |
| March 31, 2023 | -122.45M |
| December 31, 2022 | -105.10M |
| September 30, 2022 | -84.84M |
| June 30, 2022 | -54.44M |
| March 31, 2022 | -33.65M |
| December 31, 2021 | -16.82M |
| Date | Value |
|---|---|
| September 30, 2021 | -22.42M |
| June 30, 2021 | -54.05M |
| March 31, 2021 | -54.16M |
| December 31, 2020 | -18.99M |
| September 30, 2020 | -7.198M |
| June 30, 2020 | -8.286M |
| March 31, 2020 | -3.707M |
| December 31, 2019 | -30.17M |
| September 30, 2019 | -34.12M |
| June 30, 2019 | -27.74M |
| March 31, 2019 | -25.35M |
| December 31, 2018 | -27.26M |
Free Cash Flow Range, Past 5 Years
-203.53M
Minimum
Sep 2024
-3.707M
Maximum
Mar 2020
-61.87M
Average
-54.11M
Median
Free Cash Flow Benchmarks
| TC BioPharm (Holdings) PLC | -15.84M |
| Adaptimmune Therapeutics PLC | -56.05M |
| NuCana PLC | -22.00M |
| Autolus Therapeutics PLC | -205.61M |
| Biodexa Pharmaceuticals PLC | -11.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -39.83M |
| Cash from Investing (Quarterly) | -0.435M |
| Cash from Financing (Quarterly) | -31.93M |
| Free Cash Flow Per Share (Quarterly) | -0.5837 |
| Free Cash Flow to Equity (Quarterly) | -9.358M |
| Free Cash Flow to Firm (Quarterly) | -40.27M |
| Free Cash Flow Yield | -19.24% |